JP2008535856A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008535856A5 JP2008535856A5 JP2008505608A JP2008505608A JP2008535856A5 JP 2008535856 A5 JP2008535856 A5 JP 2008535856A5 JP 2008505608 A JP2008505608 A JP 2008505608A JP 2008505608 A JP2008505608 A JP 2008505608A JP 2008535856 A5 JP2008535856 A5 JP 2008535856A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- sema4d
- antibody
- cells
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66985505P | 2005-04-07 | 2005-04-07 | |
| PCT/US2006/013174 WO2006110594A2 (en) | 2005-04-07 | 2006-04-07 | Sema4d in cancer diagnosis, detection and treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008535856A JP2008535856A (ja) | 2008-09-04 |
| JP2008535856A5 true JP2008535856A5 (enExample) | 2009-05-07 |
Family
ID=36997818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008505608A Pending JP2008535856A (ja) | 2005-04-07 | 2006-04-07 | 癌の診断、検出および治療におけるｓｅｍａ４ｄ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7919246B2 (enExample) |
| EP (1) | EP1871484A2 (enExample) |
| JP (1) | JP2008535856A (enExample) |
| AU (1) | AU2006235271B2 (enExample) |
| CA (1) | CA2603780A1 (enExample) |
| WO (1) | WO2006110594A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008100995A1 (en) * | 2007-02-14 | 2008-08-21 | Vaccinex, Inc. | Humanized anti-cd100 antibodies |
| US20110160080A1 (en) | 2008-05-14 | 2011-06-30 | Chang Sherman H | Diagnosis of Melanoma and Solar Lentigo by Nucleic Acid Analysis |
| EP2427212B1 (en) | 2009-05-08 | 2017-08-23 | Vaccinex, Inc. | Anti-cd100 antibodies and methods for using the same |
| EA029023B1 (ru) | 2011-10-11 | 2018-01-31 | Вэксинекс, Инк. | Применение молекул, связывающих семафорин-4d, для модуляции проницаемости гематоэнцефалического барьера |
| CN102584946A (zh) * | 2012-03-12 | 2012-07-18 | 苏州大学 | CaM结合肽及其应用 |
| US9090709B2 (en) | 2012-03-28 | 2015-07-28 | Vaccinex, Inc. | Anti-SEMA4D antibodies and epitopes |
| US10494440B2 (en) | 2012-05-11 | 2019-12-03 | Vaccinex, Inc. | Use of semaphorin-4D binding molecules to promote neurogenesis following stroke |
| US9243068B2 (en) | 2013-06-25 | 2016-01-26 | Vaccinex, Inc. | Combination of SEMA-4D inhibitors and immunomodulators to inhibit tumors and metastases |
| NZ630881A (en) | 2013-10-10 | 2016-03-31 | Vaccinex Inc | Use of semaphorin-4d binding molecules for treatment of atherosclerosis |
| NZ630892A (en) | 2013-10-21 | 2016-03-31 | Vaccinex Inc | Use of semaphorin-4d binding molecules for treating neurodegenerative disorders |
| WO2016179043A1 (en) | 2015-05-01 | 2016-11-10 | Dermtech, Inc. | Non-invasive skin collection system |
| ES2904497T3 (es) | 2015-11-13 | 2022-04-05 | Humanscale Corp | Una estación de tecnología médica y método de uso |
| WO2017132541A1 (en) * | 2016-01-27 | 2017-08-03 | University Of Maryland, Baltimore | A method for monitoring cancer and for regulation of semaphorin 4d to improve cancer immunotherapy regimens |
| US11976332B2 (en) | 2018-02-14 | 2024-05-07 | Dermtech, Inc. | Gene classifiers and uses thereof in non-melanoma skin cancers |
| CA3134936A1 (en) | 2019-03-26 | 2020-10-01 | Dermtech, Inc. | Novel gene classifiers and uses thereof in skin cancers |
| CN116949097B (zh) * | 2023-09-20 | 2023-12-12 | 江苏集萃药康生物科技股份有限公司 | 一种sema4d人源化小鼠模型的构建方法及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6576754B2 (en) | 1995-11-09 | 2003-06-10 | Dana-Farber Cancer Institute | CD100 antigen and uses therefor |
| US7820447B2 (en) | 2000-12-22 | 2010-10-26 | Sagres Discovery Inc. | Compositions and methods for cancer |
| US7171311B2 (en) * | 2001-06-18 | 2007-01-30 | Rosetta Inpharmatics Llc | Methods of assigning treatment to breast cancer patients |
| US20060194265A1 (en) | 2001-10-23 | 2006-08-31 | Morris David W | Novel therapeutic targets in cancer |
-
2006
- 2006-04-07 CA CA002603780A patent/CA2603780A1/en not_active Abandoned
- 2006-04-07 EP EP06749576A patent/EP1871484A2/en not_active Withdrawn
- 2006-04-07 WO PCT/US2006/013174 patent/WO2006110594A2/en not_active Ceased
- 2006-04-07 JP JP2008505608A patent/JP2008535856A/ja active Pending
- 2006-04-07 US US11/918,179 patent/US7919246B2/en not_active Expired - Fee Related
- 2006-04-07 AU AU2006235271A patent/AU2006235271B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009519002A5 (enExample) | ||
| CN114599978A (zh) | 使用c-met抑制剂治疗癌症患者的方法 | |
| JP2008535494A5 (enExample) | ||
| JP2006520781A5 (enExample) | ||
| JP2008535853A5 (enExample) | ||
| RU2013113439A (ru) | Идентификация опухолеассоциированных антигенов для диагностики и терапии | |
| KR20090003308A (ko) | Ｒｅｇ４ 단백질을 이용한 췌장암 진단 방법 | |
| CN107532199B (zh) | 与间质上皮转化因子抑制剂有关的感受性预测用新型生物标志物及其用途 | |
| Xu et al. | MiR-548b suppresses proliferative capacity of colorectal cancer by binding WNT2. | |
| CA2807104C (en) | Bard1 isoforms in lung and colorectal cancer and use thereof | |
| JP2005520543A5 (enExample) | ||
| JP6005272B2 (ja) | 胃癌診断及び治療のためのａｄｃｙ３の用途 | |
| JP2008535855A5 (enExample) | ||
| WO2009141440A1 (en) | Netrin-1 overexpression as a biological marker and a survival factor for aggressive neuroblastoma | |
| JP2008535854A5 (enExample) | ||
| WO2012078648A2 (en) | Novel method of cancer diagnosis and prognosis and prediction of response to therapy | |
| JP2007508020A5 (enExample) | ||
| JP4905957B2 (ja) | Ｍｎ／ｃａ ｉｘおよび癌予後診断 | |
| JP2009523004A5 (enExample) | ||
| KR102897399B1 (ko) | 유방암 진단을 위한 신규 바이오마커 | |
| JP2008535491A5 (enExample) | ||
| KR102691995B1 (ko) | 미만형 위암의 예후 진단 마커 | |
| JP2007077155A5 (enExample) | ||
| JP2006104212A5 (enExample) | ||
| JP4967137B2 (ja) | 癌治療用組成物 |